Unprotected left main coronary artery stenting for cardiac allograft vasculopathy

J Heart Lung Transplant. 2001 Jul;20(7):776-80. doi: 10.1016/s1053-2498(00)00227-8.

Abstract

Cardiac allograft vasculopathy is the leading cause of death after the first year of transplantation. Treatment outcomes with medication, balloon angioplasty, bypass surgery, and retransplantation have been disappointing. We present our initial experience with stenting of the left main coronary artery in the setting of allograft vasculopathy.

Publication types

  • Case Reports

MeSH terms

  • Angioplasty, Balloon, Coronary / methods*
  • Anticoagulants / therapeutic use
  • Coronary Angiography
  • Coronary Disease / etiology*
  • Coronary Disease / surgery*
  • Female
  • Heart Transplantation / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Revascularization / methods*
  • Stents*
  • Transplantation, Homologous / adverse effects

Substances

  • Anticoagulants